Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology | SpringerLink
Opioids in cancer: The κ‑opioid receptor (Review)
The Kappa Opioid Receptor | SpringerLink
Kappa Receptors – Opioid Peptides
Pathways and Receptors – Opioid Peptides
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner | Molecular Psychiatry
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role | Semantic Scholar
Opioid receptors - @ a glance
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Kappa Opioid Receptor Internalization Assay - Innoprot GPCR Assays
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Z0710N Human Kappa Opioid Receptor (OPRK1) | Montana Molecular
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Opioid Receptor | kappa, mu Opioid Receptor
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development – Maine Suboxone Treatment
